Drug details

Arixtra (fondaparinux sodium)

type of Anticoagulants, Cardiovascular

Arixtra (fondaparinux) is an inhibitor of the blood clotting Factor X and is used to prevent blood clots, often in people undergoing certain surgical procedures. Arixtra should be used with extreme caution in people who have other medical conditions that cause an increased bleeding risk.

This drug may have the following side effects:

• nausea,
• headache,
• dizziness,
• vomiting,
• sleep problems (insomnia),
• skin rash,
• injection site reactions (mild bleeding, rash, itching, pain bruising, redness, and swelling),
  
• swelling of the hands/feet, or
• fever.

The following drugs are related to Arixtra, either as a replacement or used together:

• Activase (alteplase)
• Aggrastat (tirofiban hcl)
• Agrylin (anagrelide)
• Angiomax (bivalirudin)
• Miradon (anisindione)
• Bextra (valdecoxib)
• Bivalirudin (Angiomax) (bivalirudin injection)
• Zynrelef (bupivacaine and meloxicam)
• Pletal (cilostazol)
• Plavix (clopidogrel bisulfate)
• Coumadin (warfarin sodium)
• Fragmin (dalteparin)
• Iprivask (desirudin for injection)
• Lovenox (enoxaparin sodium injection)
• Integrilin (eptifibatide)
• Integrilin (etifibatide) Injection (etifibatide injection)
• Innohep (tinzaparin)
• Spinraza Solution (nusinersen)
• Streptase (streptokinase)